Vice President Of Investor Relations
CurrentGenie Therapeutics is in the business of inter alia, developing their novel DNA plasmid/gene therapy platforms for the treatment of rare skin disease along with products to be used for aesthetics/cosmic applications that reverse skin aging with a non-viral synthetic DNA that is topically applied to regenerate collagen by 300%. More information can be found here at https://www.genefacelift.comWe are currently raising capital in a Reg D 506(c)